ArticleBreast cancer research and treatment2016

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis.

Amila Orucevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.